Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

8 Items

per page
  1. Raloxifene HCl
    B1515 Raloxifene HCl
    Target: Estrogen and Related Receptors
    Summary: Estrogen receptor (ER)
      ≥22.35 mg/mL
  2. Tamoxifen Citrate
    B1394 Tamoxifen Citrate
    Target: Estrogen and Related Receptors
    Summary: Antiestrogen drug
      ≥28.2 mg/mL
  3. G-1
    B5455 G-1
     4 Citation
    Target: GPR30
    Summary: GPR30 agonist, potent and selective
      ≥41.2 mg/mL
  4. ODM-201
    A8452 ODM-201
    Target: Androgen Receptors
    Summary: new-generation androgen receptor inhibitor
  5. Medroxyprogesterone acetate
    B1510 Medroxyprogesterone acetate
    Target: Progesterone Receptors
    Summary: Steroidal progestin
  6. Naltrindole hydrochloride
    B6429 Naltrindole hydrochloride
    Summary: δ opioid antagonist
      Soluble in DMSO
  7. MDV3100 (Enzalutamide)
    A3003 MDV3100 (Enzalutamide)
     12 Citation
    Target: Androgen Receptors
    Summary: Androgen receptor antagonist
      ≥23.22 mg/mL
  8. TAK-700 (Orteronel)
    A4326 TAK-700 (Orteronel)
     2 Citation
    Target: human lyase
    Summary: Human 17,20-lyase inhibitor
      insoluble in H2O; ≥11.2 mg/mL

8 Items

per page